Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial

著者: Michael B. Atkins, Elizabeth R. Plimack, Igor Puzanov, Mayer Fishman, David F. McDermott, Daniel C. Cho, Ulka N. Vaishampayan, Saby George, Thomas Olencki, Jamal Tarazi, Brad Rosbrook, Kathrine C. Fernandez, Mariajosé Lechuga, Toni K. Choueiri - The Lancet 2018 被引用: 368